Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Computational Biology Market to Grow at a CAGR of 21% by 2023: Large Number of Applications in Academics, Industrial & Commercial Sectors

Research and Markets
Posted on: 28 Jul 17

PR Newswire

DUBLIN, July 28, 2017

DUBLIN, July 28, 2017 /PRNewswire/ --

The "Global Computational Biology Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report has been added to Research and Markets' offering.

The applications of the computational biology is boosting the growth of the market with a CAGR of around 21% during the forecast period 2016-2023. It facilitates reduction of chances for humans to consume test drugs in the development phase, easy to use, provides high data accuracy etc. Due to several advantages offered by computational biology, this technology is being extensively used in large number of applications in academics, industrial and commercial sectors.

North America has emerged as the largest market for computational biology market. The key factors contributing the growth of market in North America are the growing initiatives and investments for research and development of drug discovery, technologies of disease modeling and modernization in the existing biological computation methods. Asia pacific is the fastest growing region and is anticipated to account for large computational biology market growth with a CAGR of around 29% during the forecast period. The key reason for this growth is the increasing investments in clinical studies for pharmacokinetics and pharmacogenomics.

The global computational biology market is influenced by the presence of leading companies such as Certara (u.s.), Chemical Computing Group inc. (Canada), Insilico Biotechnology AG (Germany), Compugen ltd. (Israel) etc. Product launches, joint ventures, mergers and acquisitions are some of the crucial strategies adopted by the key market players to gain competitive advantage.


Companies Mentioned

  • Accelrys  (U.S.)
  • Certara (U.S.)
  • Chemical Computing Group Inc. (Canada)
  • Compugen Ltd.  (Israel)
  • Entelos (U.S.)
  • Genedata Ag (Switzerland)
  • Insilico Biotechnology Ag  (Germany)
  • Leadscope Inc.  ( U.S.)
  • Nimbus Technology  Llc ( U.S.)
  • Novartis (Switzerland)
  • Pfizer (U.S.)
  • Roche (Switzerland)
  • Sanofi Pasteur (France)
  • Schrodinger Llc ( U.S.)
  • Simulation Plus Inc. (U.S.)

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Geographical Analysis

7. Company Profiles 

For more information about this report visit https://www.researchandmarkets.com/research/rlrhd7/global

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



View original content:http://www.prnewswire.com/news-releases/global-computational-biology-market-to-grow-at-a-cagr-of-21-by-2023-large-number-of-applications-in-academics-industrial--commercial-sectors-300496065.html

SOURCE Research and Markets

PR Newswire
www.prnewswire.com

Last updated on: 28/07/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.